Advaxis Inc. | Key People and Executives

David Sidransky
Chairman
Kenneth A. Berlin
President, Chief Executive Officer & Director
James P. Patton
Vice Chairman
Samir N. Khleif
Independent Director
Thomas J. McKearn
Independent Director
Richard J. Berman
Independent Director
Roni A. Appel
Independent Director
David Sidransky
Chairman
Kenneth A. Berlin
President, Chief Executive Officer & Director
Molly Henderson
Chief Financial Officer & Executive Vice President
Andres A. GutiƩrrez
Chief Medical Officer
Michael Grace
Vice President-Technical Operations
Al Blunt
Vice President-Medical
Robert G. Petit
Chief Scientific Officer & Executive VP
Ranya Dajani
Vice President-Business Development
Thomas W. Hare
Senior Vice President-Product Development
Noelle Heber
Senior Director-Corporate Communications
James P. Patton
Vice Chairman
Samir N. Khleif
Independent Director
Thomas J. McKearn
Independent Director
Richard J. Berman
Independent Director
Roni A. Appel
Independent Director

About Advaxis

View Profile
Address
305 College Road East
Princeton New Jersey 08540
United States
Employees -
Website http://www.advaxis.com
Updated 07/08/2019
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy.